{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:38:06Z","timestamp":1758893886880},"reference-count":33,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1507\/endocrj.ej22-0564","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T22:16:16Z","timestamp":1683843376000},"page":"839-846","source":"Crossref","is-referenced-by-count":5,"title":["A case of osteogenesis imperfecta caused by a &lt;i&gt;COL1A1&lt;\/i&gt; variant, coexisting with pituitary stalk interruption syndrome"],"prefix":"10.1507","volume":"70","author":[{"given":"Takuya","family":"Kitamura","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"},{"name":"Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kusakabe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Tsuiki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Nanba","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"},{"name":"Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaho","family":"Hiroshima-Hamanaka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Satoh-Asahara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Yasoda","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tagami","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"},{"name":"Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16: 101\u2013116.","DOI":"10.1136\/jmg.16.2.101"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Lindahl K, \u00c5str\u00f6m E, Rubin CJ, Grigelioniene G, Malmgren B, et al. (2015) Genetic epidemiology, prevalence, and genotype-phenotype correlations in the Swedish population with osteogenesis imperfecta. Eur J Hum Genet 23: 1042\u20131050.","DOI":"10.1038\/ejhg.2015.81"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Tournis S, Dede AD (2018) Osteogenesis imperfecta\u2014A clinical update. Metabolism 80: 27\u201337.","DOI":"10.1016\/j.metabol.2017.06.001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Trejo P, Rauch F (2016) Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment. Osteoporos Int 27: 3427\u20133437.","DOI":"10.1007\/s00198-016-3723-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Maioli M, Gnoli M, Boarini M, Tremosini M, Zambrano A, et al. (2019) Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients. Eur J Hum Genet 27: 1090\u20131100.","DOI":"10.1038\/s41431-019-0373-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Van Dijk FS, Sillence DO (2014) Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 164A: 1470\u20131481.","DOI":"10.1002\/ajmg.a.36545"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7 Wang CZ, Guo LL, Han BY, Su X, Guo QH, et al. (2017) Pituitary stalk interruption syndrome: from clinical findings to pathogenesis. J Neuroendocrinol 29. doi: 10.1111\/jne.12451.","DOI":"10.1111\/jne.12451"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Fernandez-Rodriguez E, Quinteiro C, Barreiro J, Marazuela M, Pereiro I, et al. (2011) Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: prevalence, evolution of hormone dysfunction and genetic analysis. Neuroendocrinology 93: 181\u2013188.","DOI":"10.1159\/000324087"},{"key":"#cr-split#-9.1","unstructured":"9 Isojima T, Kato N, Ito Y, Kanzaki S, Murata M (2016) Growth standard charts for Japanese children with mean and standard deviation"},{"key":"#cr-split#-9.2","unstructured":"(SD) values based on the year 2000 national survey. Clin Pediatr Endocrinol 25: 71-76."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Zhytnik L, Maasalu K, Reimand T, Duy BH, K\u00f5ks S, et al. (2020) Inter- and intrafamilial phenotypic variability in individuals with collagen-related osteogenesis imperfecta. Clin Transl Sci 13: 960\u2013971.","DOI":"10.1111\/cts.12783"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Ries-Levavi L, Ish-Shalom T, Frydman M, Lev D, Cohen S, et al. (2004) Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients. Hum Mutat 23: 399\u2013400.","DOI":"10.1002\/humu.9230"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Zhytnik L, Maasalu K, Pashenko A, Khmyzov S, Reimann E, et al. (2019) COL1A1\/2 pathogenic variants and phenotype characteristics in Ukrainian osteogenesis imperfecta patients. Front Genet 10: 722.","DOI":"10.3389\/fgene.2019.00722"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Rowe DW, Shapiro JR, Poirier M, Schlesinger S (1985) Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta. J Clin Invest 76: 604\u2013611.","DOI":"10.1172\/JCI112012"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Pereira R, Halford K, Sokolov BP, Khillan JS, Prockop DJ (1994) Phenotypic variability and incomplete penetrance of spontaneous fractures in an inbred strain of transgenic mice expressing a mutated collagen gene (COL1A1). J Clin Invest 93: 1765\u20131769.","DOI":"10.1172\/JCI117161"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15 Hannah ME, Hannah WJ, Hewson SA, Hodnett ED, Saigal S, et al. (2000) Planned caesarean section <i>versus <\/i>planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group. Lancet 356: 1375\u20131383.","DOI":"10.1016\/S0140-6736(00)02840-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Cubert R, Cheng EY, Mack S, Pepin MG, Byers PH (2001) Osteogenesis imperfecta: mode of delivery and neonatal outcome. Obstet Gynecol 97: 66\u201369.","DOI":"10.1097\/00006250-200101000-00014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Wang Q, Hu Y, Li G, Sun X (2014) Pituitary stalk interruption syndrome in 59 children: the value of MRI in assessment of pituitary functions. Eur J Pediatr 173: 589\u2013595.","DOI":"10.1007\/s00431-013-2214-1"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18 Fujisawa I, Kikuchi K, Nishimura K, Togashi K, Itoh K, et al. (1987) Transection of the pituitary stalk: development of an ectopic posterior lobe assessed with MR imaging. Radiology 165: 487\u2013489.","DOI":"10.1148\/radiology.165.2.3659371"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Wang D, Zhang M, Guan H, Wang X (2019) Osteogenesis imperfecta due to combined heterozygous mutations in both COL1A1 and COL1A2, coexisting with pituitary stalk interruption syndrome. Front Endocrinol (Lausanne) 10: 193.","DOI":"10.3389\/fendo.2019.00193"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Vergier J, Castinetti F, Saveanu A, Girard N, Brue T, et al. (2019) Diagnosis of endocrine disease: pituitary stalk interruption syndrome: etiology and clinical manifestations. Eur J Endocrinol 181: R199\u2013R209.","DOI":"10.1530\/EJE-19-0168"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Hasegawa Y, Hasegawa T, Yokoyama T, Kotoh S, Tsuchiya Y (1992) Gradual progress of ACTH deficiency in a child with panhypopituitarism associated with pituitary stalk transection. Endocrinol Jpn 39: 165\u2013167.","DOI":"10.1507\/endocrj1954.39.165"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Genovese E, Maghnie M, Beluffi G, Villa A, Sammarchi L, et al. (1997) Hypothalamic-pituitary vascularization in pituitary stalk transection syndrome: is the pituitary stalk really transected? The role of gadolinium-DTPA with spin-echo T1 imaging and turbo-FLASH technique. Pediatr Radiol 27: 48\u201353.","DOI":"10.1007\/s002470050062"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Wang W, Wang S, Jiang Y, Yan F, Su T, et al. (2015) Relationship between pituitary stalk (PS) visibility and the severity of hormone deficiencies: PS interruption syndrome revisited. Clin Endocrinol (Oxf) 83: 369\u2013376.","DOI":"10.1111\/cen.12788"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Hemwong N, Phokaew C, Srichomthong C, Tongkobpetch S, Srilanchakon K, et al. (2020) A patient with combined pituitary hormone deficiency and osteogenesis imperfecta associated with mutations in LHX4 and COL1A2. J Adv Res 21: 121\u2013127.","DOI":"10.1016\/j.jare.2019.10.006"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Lin HY, Chuang CK, Su YN, Chen MR, Chiu HC, et al. (2015) Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta. Orphanet J Rare Dis 10: 152.","DOI":"10.1186\/s13023-015-0370-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, et al. (1987) Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 106: 354\u2013361.","DOI":"10.7326\/0003-4819-106-3-"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM (1994) Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 78: 669\u2013674.","DOI":"10.1210\/jcem.78.3.8126140"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, et al. (2004) Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89: 2085\u20132098.","DOI":"10.1210\/jc.2003-032006"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29 Land C, Rauch F, Travers R, Glorieux FH (2007) Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment. Bone 40: 638\u2013644.","DOI":"10.1016\/j.bone.2006.10.010"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Uehara M, Nakamura Y, Nakano M, Miyazaki A, Suzuki T, et al. (2022) Efficacy of romosozumab for osteoporosis in a patient with osteogenesis imperfecta: a case report. Mod Rheumatol Case Rep 6: 128\u2013133.","DOI":"10.1093\/mrcr\/rxab018"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Suzuki S, Ruike Y, Ishiwata K, Naito K, Igarashi K, et al. (2022) Clinical usefulness of the growth hormone-releasing peptide-2 test for hypothalamic-pituitary disorder. J Endocr Soc 6: bvac088.","DOI":"10.1210\/jendso\/bvac088"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Yanase T, Tajima T, Katabami T, Iwasaki Y, Tanahashi Y, et al. (2016) Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline [Opinion]. Endocr J 63: 765\u2013784.","DOI":"10.1507\/endocrj.EJ16-0242"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/8\/70_EJ22-0564\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:48:36Z","timestamp":1715575716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/70\/8\/70_EJ22-0564\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej22-0564","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"EJ22-0564"}}